title: Effect of bovine apo-lactoferrin on the growth and virulence of Actinobacillus pleuropneumoniae.
abstract: Actinobacillus pleuropneumoniae (App) is a Gram-negative bacterium that causes porcine pleuropneumonia, leading to economic losses in the swine industry. Due to bacterial resistance to antibiotics, new treatments for this disease are currently being sought. Lactoferrin (Lf) is an innate immune system glycoprotein of mammals that is microbiostatic and microbicidal and affects several bacterial virulence factors. The aim of this study was to investigate whether bovine iron-free Lf (BapoLf) has an effect on the growth and virulence of App. Two serotype 1 strains (reference strain S4074 and the isolate BC52) and a serotype 7 reference strain (WF83) were analyzed. First, the ability of App to grow in iron-charged BLf was discarded because in vivo, BapoLf sequesters iron and could be a potential source of this element favoring the infection. The minimum inhibitory concentration of BapoLf was 14.62, 11.78 and 10.56 µM for the strain BC52, S4074 and WF83, respectively. A subinhibitory concentration (0.8 µM) was tested by assessing App adhesion to porcine buccal epithelial cells, biofilm production, and the secretion and function of toxins and proteases. Decrease in adhesion (24-42 %) was found in the serotype 1 strains. Biofilm production decreased (27 %) for only the strain 4074 of serotype 1. Interestingly, biofilm was decreased (60-70 %) in the three strains by BholoLf. Hemolysis of erythrocytes and toxicity towards HeLa cells were not affected by BapoLf. In contrast, proteolytic activity in all strains was suppressed in the presence of BapoLf. Finally, oxytetracycline produced synergistic effect with BapoLf against App. Our results suggest that BapoLf affects the growth and several of the virulence factors in App.
authors.affiliation: Departamento de Biología Celular, Centro de Investigación y de Estudios Avanzados del IPN (CINVESTAV-IPN), Ave. IPN 2508, 07360, México DF, Mexico.
authors.forename: Sarahí
authors.initials: S
authors.lastname: Luna-Castro
authors.forename: Francisco
authors.initials: F
authors.lastname: Aguilar-Romero
authors.forename: Luisa
authors.initials: L
authors.lastname: Samaniego-Barrón
authors.forename: Delfino
authors.initials: D
authors.lastname: Godínez-Vargas
authors.forename: Mireya
authors.initials: M
authors.lastname: de la Garza
mesh_terms: D000189:Actinobacillus Infections / Q000209:etiology / Q000662:veterinary; D016977:Actinobacillus pleuropneumoniae / Q000254:growth & development* / Q000472:pathogenicity* / Q000502:physiology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D023181:Antimicrobial Cationic Peptides / Q000008:administration & dosage / Q000276:immunology / Q000502:physiology; D001059:Apoproteins / Q000008:administration & dosage / Q000276:immunology / Q000502:physiology*; D001422:Bacterial Adhesion; D001427:Bacterial Toxins / Q000096:biosynthesis; D018441:Biofilms / Q000187:drug effects / Q000254:growth & development; D002417:Cattle; D004357:Drug Synergism; D006367:HeLa Cells; D006801:Humans; D007501:Iron / Q000378:metabolism; D007781:Lactoferrin / Q000008:administration & dosage / Q000276:immunology / Q000502:physiology*; D010118:Oxytetracycline / Q000008:administration & dosage; D011001:Pleuropneumonia / Q000209:etiology / Q000662:veterinary; D013552:Swine; D013553:Swine Diseases / Q000209:etiology; D014774:Virulence
chemical_list: D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D001059:Apoproteins; D001427:Bacterial Toxins; C039223:apolactoferrin; D007501:Iron; D007781:Lactoferrin; D010118:Oxytetracycline